Literature DB >> 15931355

Soluble form of the triggering receptor expressed on myeloid cells-1 as a marker of microbial infection.

Sébastien Gibot1, Aurélie Cravoisy.   

Abstract

Sepsis is a common cause of morbidity and mortality in intensive care units. Unfortunately, there is no gold standard for diagnosing sepsis as clinical and laboratory signs are neither sensitive enough nor specific enough, and microbiological studies often remain negative. Thus, there is a need for clinical or laboratory tools to distinguish between sepsis and non-infectious inflammatory disorders. Among the potentially useful markers of sepsis, procalcitonin has been suggested to be the most promising, although results are variable depending on the severity of illness and degree of infection in the patient population studied. The triggering receptor expressed on myeloid cells-1 (TREM-1) is a member of the immunoglobulin superfamily, of which expression is upregulated on phagocytic cells in the presence of bacteria or fungi. Here we report on the potential usefulness of assessing the soluble form of TREM-1 (sTREM-1) in biological fluids for the diagnosis of microbial infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15931355      PMCID: PMC1069091          DOI: 10.3121/cmr.2.3.181

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


  23 in total

1.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.

Authors:  J L Vincent; R Moreno; J Takala; S Willatts; A De Mendonça; H Bruining; C K Reinhart; P M Suter; L G Thijs
Journal:  Intensive Care Med       Date:  1996-07       Impact factor: 17.440

2.  Lack of specificity of procalcitonin for sepsis diagnosis in premature infants.

Authors:  A Lapillonne; E Basson; G Monneret; J Bienvenu; B L Salle
Journal:  Lancet       Date:  1998-04-18       Impact factor: 79.321

3.  Strategies and options for minimizing resistance emergence in pulmonary infections.

Authors:  S G Amyes
Journal:  Chest       Date:  1998-03       Impact factor: 9.410

4.  Procalcitonin concentrations in patients with neutropenic fever.

Authors:  E Ruokonen; T Nousiainen; K Pulkki; J Takala
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-04       Impact factor: 3.267

5.  Procalcitonin used as a marker of infection in the intensive care unit.

Authors:  H Ugarte; E Silva; D Mercan; A De Mendonça; J L Vincent
Journal:  Crit Care Med       Date:  1999-03       Impact factor: 7.598

6.  Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid.

Authors:  J Pugin; R Auckenthaler; N Mili; J P Janssens; P D Lew; P M Suter
Journal:  Am Rev Respir Dis       Date:  1991-05

7.  High serum procalcitonin concentrations in patients with sepsis and infection.

Authors:  M Assicot; D Gendrel; H Carsin; J Raymond; J Guilbaud; C Bohuon
Journal:  Lancet       Date:  1993-02-27       Impact factor: 79.321

8.  Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis.

Authors:  Sébastien Gibot; Marie-Nathalie Kolopp-Sarda; Marie C Béné; Aurélie Cravoisy; Bruno Levy; Gilbert C Faure; Pierre-Edouard Bollaert
Journal:  Ann Intern Med       Date:  2004-07-06       Impact factor: 25.391

Review 9.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

Authors:  R C Bone; R A Balk; F B Cerra; R P Dellinger; A M Fein; W A Knaus; R M Schein; W J Sibbald
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

10.  The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study.

Authors:  M S Rangel-Frausto; D Pittet; M Costigan; T Hwang; C S Davis; R P Wenzel
Journal:  JAMA       Date:  1995-01-11       Impact factor: 56.272

View more
  38 in total

1.  sTREM-1, sIL-2Rα, and IL-6, but not sCD163, might predict sepsis in polytrauma patients: a prospective cohort study.

Authors:  S Trancă; J T Oever; C Ciuce; M Netea; A Slavcovici; C Petrișor; N Hagău
Journal:  Eur J Trauma Emerg Surg       Date:  2016-05-12       Impact factor: 3.693

2.  Hypoxic Stress Induced TREM-1 and Inflammatory Chemokines in Human Peripheral Blood Mononuclear Cells.

Authors:  K P Mishra; Sonal Jain; Lilly Ganju; S B Singh
Journal:  Indian J Clin Biochem       Date:  2013-05-28

Review 3.  Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis?

Authors:  Dubravka Kojic; Benedikt H Siegler; Florian Uhle; Christoph Lichtenstern; Peter P Nawroth; Markus A Weigand; Stefan Hofer; Thorsten Brenner
Journal:  World J Exp Med       Date:  2015-05-20

4.  Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease.

Authors:  Michalis Tzivras; Vassilios Koussoulas; Evangelos J Giamarellos-Bourboulis; Dimitrios Tzivras; Thomas Tsaganos; Pantelis Koutoukas; Helen Giamarellou; Athanasios Archimandritis
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

Review 5.  Aspiration-induced lung injury.

Authors:  Krishnan Raghavendran; Jean Nemzek; Lena M Napolitano; Paul R Knight
Journal:  Crit Care Med       Date:  2011-04       Impact factor: 7.598

Review 6.  Biomarkers for ventilator-associated pneumonia: review of the literature.

Authors:  Steven J Palazzo; Terri Simpson; Lynn Schnapp
Journal:  Heart Lung       Date:  2011-03-21       Impact factor: 2.210

Review 7.  Biomarkers in the diagnosis of aspiration syndromes.

Authors:  Philippe Abou Jaoude; Paul R Knight; Patricia Ohtake; Ali A El-Solh
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

Review 8.  Triggering receptor expressed on myeloid cells type 1 as a potential therapeutic target in sepsis.

Authors:  Steven J Palazzo; Terri Simpson; Lynn M Schnapp
Journal:  Dimens Crit Care Nurs       Date:  2012 Jan-Feb

Review 9.  Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia.

Authors:  Mirjam Christ-Crain; Steven M Opal
Journal:  Crit Care       Date:  2010-02-08       Impact factor: 9.097

Review 10.  Biomarkers: a definite plus in pneumonia.

Authors:  Hanssa Summah; Jie-Ming Qu
Journal:  Mediators Inflamm       Date:  2009       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.